Human DNA Vaccines Market
Human DNA vaccines have advanced significantly in the 20 years since their invention, but they have yet to become a viable alternative to traditional protein or carbohydrate-based human vaccines. While safety concerns were an initial impediment, Human DNA vaccines Achilles heel remains their low immunogenicity when compared to protein vaccines. To improve Human DNA vaccine immunogenicity, a variety of strategies have been developed, including codon optimization, genetic adjuvants, electroporation, and sophisticated prime-boost regimens, with each method having advantages and limitations.
Read More:
https://cmitoc.blogspot.com/2022/06/human-dna-vaccines-are-highly-effective.html
